Establishment and Evaluation of Propidium Monoazide-Digital Pcr (Pma-Dpcr) for Rapid Discrimination of Infectious Sars-Cov-2
Dandan Liu(Anhui Medical University), Lunbiao Cui(Jiangsu Provincial Center for Disease Control and Prevention), Junhong Luo(Nanjing Medical University), Ning Yang(Jiangsu University), Fengcai Zhu(Jiangsu Provincial Center for Disease Control and Prevention), Bailin An(Nankai University), Qiao Qiao(First Hospital of China Medical University), Tao Wu(Jiangsu Provincial Center for Disease Control and Prevention), Kangchen Zhao(Jiangsu Provincial Center for Disease Control and Prevention), Yiyue Ge(Jiangsu Provincial Center for Disease Control and Prevention), Yunfeng Shan(Chinese Center For Disease Control and Prevention), Xiaojuan Zhu(East China University of Science and Technology)
Cited by 1
Related Papers
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial
|The Lancet Infectious Diseases|2020|1.5k
Co-infection with respiratory pathogens among COVID-2019 cases
|Virus Research|2020|637
Serum Cytokine and Chemokine Profile in Relation to the Severity of Coronavirus Disease 2019 in China
|The Journal of Infectious Diseases|2020|391
A Family Cluster of Infections by a Newly Recognized Bunyavirus in Eastern China, 2007: Further Evidence of Person-to-Person Transmission
|Clinical Infectious Diseases|2011|268
An integrative drug repositioning framework discovered a potential therapeutic agent targeting COVID-19
|Signal Transduction and Targeted Therapy|2021|204